ScreenerHero
SPISpire Healthcare Group PLC
LSE · GB · Healthcare · Medical Care Facilities · spirehealthcare.com
234.00GBP-0.85%Mkt Cap: 1.21B $P/E: 59.00

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides di…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$90.30BUSDP/E 13.7
FRE
Fresenius SE & Co. KGaA
$28.53BUSDP/E 16.8
THC
Tenet Healthcare Corporation
$21.62BUSDP/E 10.4
FME
Fresenius Medical Care AG
$11.72BUSDP/E 12.1
EHC
Encompass Health Corporation
$12.01BUSDP/E 20.3
DVA
DaVita Inc.
$11.38BUSDP/E 15.0
ENSG
The Ensign Group, Inc.
$10.64BUSDP/E 28.6
UHS
Universal Health Services, Inc. Class B
$10.16BUSDP/E 7.0
PACS
PACS Group Inc.
$7.01BUSDP/E 25.9
CHE
Chemed Corporation
$7.00BUSDP/E 26.9
LFST
LifeStance Health Group Inc. Common Stock
$4.90BUSDP/E 98.7
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.43BUSDP/E 22.4
MCOV-B
Medicover AB (publ)
$3.50BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.67BUSDP/E 26.3
OPCH
Option Care Health, Inc.
$3.50BUSDP/E 17.7
BKD
Brookdale Senior Living Inc.
$2.89BUSD
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.4
EMEIS
EMEIS
$2.45BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.55BUSD
GRDN
Guardian Pharmacy Services Inc. Class A Common Stock
$2.41BUSDP/E 36.5

Key Statistics

Company
Market Cap1.21B $
Enterprise Value2.86B $
Revenue (TTM)2.03B $
Gross Profit918.48M $
Net Income (TTM)21.03M $
Revenue/Share5.061 USD
Last Price234.00 GBP
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees17.8K
CountryGB
SectorHealthcare
IndustryMedical Care Facilities
ISINGB00BNLPYF73
Valuation
P/E (Trailing)59.00
P/E (Forward)17.38
PEG—
EV/EBITDA10.35
EV/Revenue1.41
P/S0.59
P/B1.26
EPS (TTM)0.04
EPS (Forward)0.13
52W Range
140.8081% of range256.50
52W High256.50 GBP
52W Low140.80 GBP
Profitability
Gross Margin45.33%
Oper. Margin9.05%
EBITDA Margin13.63%
Profit Margin1.04%
ROE2.21%
ROA0.69%
Growth
Revenue Growth4.60%
Earnings Growth-19.30%
Cash Flow & Leverage
Operating CF310.65M $
CapEx (TTM)100.68M $
FCF Margin4.20%
FCF Yield7.02%
Net Debt1.64B $
Net Debt/EBITDA5.95
Balance Sheet
Debt/Equity1.77
Current Ratio0.64
Quick Ratio0.39
Book Value/Sh1.854 GBP
Cash/Share0.0870 GBP
Dividends
Fwd Div Rate0.0200 GBP
Trail. Div Rate0.0150 GBP
Div. Yield0.64%
5Y Avg Yield2.02%
Payout Ratio57.50%
Ex-Div DateMay 21, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)256.20 GBP
Upside (mean)+9.5%
Target Range179.00 GBP – 300.00 GBP
GBP179.00+9.5% to meanGBP300.00
# Analysts5
Ownership
Shares Out.400.60M
Float181.94M
Insiders36.41%
Institutions55.28%
Technical
SMA 50223.38 (+4.8%)
SMA 200195.30 (+19.8%)
Beta0.93
S&P 52W Chg18.16%
Avg Vol (30d)1.18M
Avg Vol (10d)864.61K
Technical Indicators
RSI (14)64.6
MACD3.7823
MACD Signal3.9226
MACD Hist.-0.1403
BB Upper240.01 GBP
BB Middle231.38 GBP
BB Lower222.74 GBP
BB Width7.46%
ATR (14)4.834 GBP
Vol Ratio (20d)0.66x